That reflects the new dynamics in the marketplace, where we have heightened competition in several major therapy areas, including diabetes, with manufacturers taking price concessions through rebates. Murray Aitken More Quotes by Murray Aitken More Quotes From Murray Aitken Our spending on those drugs will be relatively high but still manageable... because they will be offset by more modest price increases for branded drugs and a rising level of savings from drugs losing patent protection. Murray Aitken company-news We're in for a period of intense competition among alternative treatments, which is a different dynamic than we've seen in the past where the progress has been a little slower and individual drugs had a little more time. Murray Aitken company-news $ 100 billion is a significant proportion of total spending on medicines and total healthcare costs, but it's part of the healthcare system that's producing great results and bringing great benefit to patients. Murray Aitken company-news Within the U.S. market, we are seeing in aggregate higher levels of rebate, especially in the diabetes and respiratory therapy areas. Murray Aitken health-news
